Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Kyverna Therapeutics
Research
In the wake of Céline Dion's comeback, SPS marches toward a cure
Stiff-person syndrome is not well understood and currently has no cure. But, in the wake of Céline Dion’s diagnosis, that may finally be changing.
Darren Incorvaia
Aug 15, 2024 2:45pm
Kyverna's CAR-T relapse in lupus dents autoimmune hopes
Jun 17, 2024 8:51am
Funding at 'new normal' until interest rates change: PitchBook
Jun 6, 2024 12:01am
How 'remarkable' results in lupus carried CAR-T to immunology
May 30, 2024 9:00am
Kyverna CEO: 'We're in the next phase of medicine'
Feb 9, 2024 1:57pm
Kyverna overshoots raised IPO expectations with $319M offering
Feb 8, 2024 8:24am